GW Henssler & Associates Ltd. cut its stake in Thermo Fisher Scientific Inc (NYSE:TMO) by 8.8% during the third quarter, Holdings Channel reports. The firm owned 53,823 shares of the company’s stock after selling 5,176 shares during the period. GW Henssler & Associates Ltd.’s holdings in Thermo Fisher Scientific were worth $8,561,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of the company. Bank of Montreal Can purchased a new position in Thermo Fisher Scientific during the second quarter valued at approximately $32,053,000. Daiwa Securities Group Inc. boosted its position in Thermo Fisher Scientific by 2.0% in the second quarter. Daiwa Securities Group Inc. now owns 9,994 shares of the company’s stock valued at $1,477,000 after buying an additional 200 shares during the period. Meeder Asset Management Inc. boosted its position in Thermo Fisher Scientific by 114.6% in the second quarter. Meeder Asset Management Inc. now owns 14,324 shares of the company’s stock valued at $2,117,000 after buying an additional 7,650 shares during the period. Hermes Investment Management Ltd. boosted its position in Thermo Fisher Scientific by 10.0% in the second quarter. Hermes Investment Management Ltd. now owns 316,837 shares of the company’s stock valued at $46,816,000 after buying an additional 28,900 shares during the period. Finally, Robeco Institutional Asset Management B.V. boosted its position in Thermo Fisher Scientific by 1.0% in the second quarter. Robeco Institutional Asset Management B.V. now owns 156,475 shares of the company’s stock valued at $23,122,000 after buying an additional 1,538 shares during the period. Hedge funds and other institutional investors own 86.19% of the company’s stock.

Institutional Ownership by Quarter for Thermo Fisher Scientific (NYSE:TMO)

Thermo Fisher Scientific Inc (NYSE:TMO) traded up 0.11% on Friday, reaching $146.13. 131,158 shares of the company’s stock traded hands. Thermo Fisher Scientific Inc has a 52-week low of $119.75 and a 52-week high of $160.68. The firm has a market cap of $57.73 billion, a price-to-earnings ratio of 29.21 and a beta of 1.17. The stock’s 50 day moving average is $143.18 and its 200 day moving average is $150.33.

Thermo Fisher Scientific (NYSE:TMO) last posted its quarterly earnings data on Thursday, October 27th. The company reported $2.03 earnings per share for the quarter, beating the consensus estimate of $1.97 by $0.06. The firm earned $4.49 billion during the quarter, compared to analysts’ expectations of $4.39 billion. Thermo Fisher Scientific had a net margin of 11.10% and a return on equity of 14.95%. The company’s quarterly revenue was up 8.9% compared to the same quarter last year. During the same quarter last year, the company posted $1.80 EPS. On average, equities research analysts predict that Thermo Fisher Scientific Inc will post $8.25 EPS for the current fiscal year.

The business also recently disclosed a quarterly dividend, which will be paid on Monday, January 16th. Shareholders of record on Thursday, December 15th will be given a $0.15 dividend. This represents a $0.60 annualized dividend and a yield of 0.41%. The ex-dividend date of this dividend is Tuesday, December 13th. Thermo Fisher Scientific’s payout ratio is presently 12.00%.

COPYRIGHT VIOLATION WARNING: This article was first posted by Daily Political and is owned by of Daily Political. If you are reading this article on another site, it was copied illegally and reposted in violation of US and international copyright & trademark legislation. The original version of this article can be viewed at http://www.dailypolitical.com/2017/01/13/thermo-fisher-scientific-inc-tmo-stake-cut-by-gw-henssler-associates-ltd.html.

Several research analysts have recently issued reports on the stock. Bank of America Corporation set a $180.00 price objective on shares of Thermo Fisher Scientific and gave the company a “buy” rating in a report on Friday, October 7th. J P Morgan Chase & Co assumed coverage on shares of Thermo Fisher Scientific in a report on Thursday, September 22nd. They issued an “overweight” rating and a $180.00 price objective for the company. Zacks Investment Research upgraded shares of Thermo Fisher Scientific from a “hold” rating to a “buy” rating and set a $172.00 price objective for the company in a report on Thursday, October 13th. Leerink Swann assumed coverage on shares of Thermo Fisher Scientific in a report on Thursday, November 10th. They issued an “outperform” rating and a $175.00 price objective for the company. Finally, Goldman Sachs Group, Inc. (The) reiterated a “conviction-buy” rating and issued a $168.00 price objective (down from $170.00) on shares of Thermo Fisher Scientific in a report on Monday, December 12th. Three research analysts have rated the stock with a hold rating, thirteen have given a buy rating and one has issued a strong buy rating to the company’s stock. The stock currently has an average rating of “Buy” and a consensus price target of $165.22.

Thermo Fisher Scientific Company Profile

Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company is a provider of analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. The company operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

5 Day Chart for NYSE:TMO

Want to see what other hedge funds are holding TMO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Thermo Fisher Scientific Inc (NYSE:TMO).

Receive News & Ratings for Thermo Fisher Scientific Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific Inc and related companies with MarketBeat.com's FREE daily email newsletter.